Mode
Text Size
Log in / Sign up
N/A N=8 Randomized Health Services Research

Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team

Common Infections · Urinary Tract Infections · Pneumonia

Enrolled (actual)
8
Serious AEs
Results posted
May 2026
Primary outcome: Primary: Days of Antibiotic Therapy Per 1000 Days of Care — 710; 744 Days of Antibiotic Therapy/1000 Bed Days

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Antibiotic Use Report (Other)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Mar 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Days of Antibiotic Therapy Per 1000 Days of Care
710; 744
SECONDARY
Days of Broad-spectrum Antibiotic Therapy Per 1000 Bed Days of Care
127; 188
SECONDARY
Antibiotic Starts (New Prescriptions)/1000 Bed Days of Care
231; 226

Summary

Antimicrobial-resistant and healthcare-associated pathogens are a global health threat. The goals of antimicrobial stewardship are to minimize unnecessary and inappropriate antimicrobial use as a means to combat antimicrobial resistance. Previously, the investigators implemented a Videoconference Antimicrobial Stewardship Team (VAST) at 2 VA Medical Centers (VAMCs), using telehealth to connect clinicians at a rural VAMC to a geographically distant infectious disease expert Both VASTs successfully decreased overall antibiotic use in acute and long-term care units. This project will expand the VAST approach to other VAMCs and test the hypothesis that quarterly reports that quantify facility-level antibiotic use will enhance the efficacy of VASTs to support antimicrobial stewardship. This work will directly increase access to antimicrobial stewardship consultation at rural VA facilities, which are often underserved by infectious disease expertise.

Eligibility Criteria

Inclusion Criteria

  • VA medical centers without local ID expertise that pair with an ID-expert from another VA medical center.

Exclusion Criteria

  • (none)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05319561). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search